Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort
- PMID: 36283610
- DOI: 10.1016/j.cmi.2022.10.019
Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort
Abstract
Objectives: To analyse the adherence and impact of quality-of-care indicators (QCIs) in the management of Staphylococcus aureus bloodstream infection in a prospective and multicentre cohort.
Methods: Analysis of the prospective, multicentre international S. Aureus Collaboration cohort of S. Aureus bloodstream infection cases observed between January 2013 and April 2015. Multivariable analysis was performed to evaluate the impact of adherence to QCIs on 90-day mortality.
Results: A total of 1784 cases were included. Overall, 90-day mortality was 29.9% and mean follow-up period was 118 days. Adherence was 67% (n = 1180/1762) for follow-up blood cultures, 31% (n = 416/1342) for early focus control, 77.6% (n = 546/704) for performance of echocardiography, 75.5% (n = 1348/1784) for adequacy of targeted antimicrobial therapy, 88.6% (n = 851/960) for adequacy of treatment duration in non-complicated bloodstream infections and 61.2% (n = 366/598) in complicated bloodstream infections. Full bundle adherence was 18.4% (n = 328/1784). After controlling for immortal time bias and potential confounders, focus control (adjusted hazard ratio = 0.76; 95% CI, 0.59-0.99; p 0.038) and adequate targeted antimicrobial therapy (adjusted hazard ratio = 0.75; 95% CI, 0.61-0.91; p 0.004) were associated with low 90-day mortality.
Discussion: Adherence to QCIs in S. Aureus bloodstream infection did not reach expected rates. Apart from the benefits of application as a bundle, focus control and adequate targeted therapy were independently associated with low mortality.
Keywords: Management; Mortality; Quality of care indicators; Staphylococcus aureus.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.Infection. 2017 Feb;45(1):83-91. doi: 10.1007/s15010-016-0946-3. Epub 2016 Oct 5. Infection. 2017. PMID: 27709434
-
The impact of infectious diseases consultation for children with Staphylococcus aureus bacteremia.Pediatr Res. 2022 Dec;92(6):1598-1605. doi: 10.1038/s41390-022-02251-0. Epub 2022 Aug 18. Pediatr Res. 2022. PMID: 35982140 Free PMC article.
-
Impact on mortality of adherence to evidence-based interventions in patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus.Infect Dis (Lond). 2018 Nov-Dec;50(11-12):837-846. doi: 10.1080/23744235.2018.1501513. Epub 2018 Oct 16. Infect Dis (Lond). 2018. PMID: 30325676
-
Essentials in the management of S. aureus bloodstream infection.Infection. 2018 Aug;46(4):441-442. doi: 10.1007/s15010-018-1130-8. Epub 2018 Mar 6. Infection. 2018. PMID: 29512028 Review.
-
High success rate in salvage of catheter-related bloodstream infections due to Staphylococcus aureus, on behalf of project group of Italian society of nephrology.J Vasc Access. 2020 May;21(3):336-341. doi: 10.1177/1129729819875323. Epub 2019 Sep 12. J Vasc Access. 2020. PMID: 31512986 Review.
Cited by
-
Association Between Infectious Diseases Consultation and Mortality in Hospitalized Patients With Gram-negative Bloodstream Infection: A Retrospective Population-wide Cohort Study.Clin Infect Dis. 2024 Oct 15;79(4):855-863. doi: 10.1093/cid/ciae282. Clin Infect Dis. 2024. PMID: 38758977 Free PMC article.
-
Adherence to and clinical utility of "quality indicators" for Staphylococcus aureus bacteremia: a retrospective, multicenter study.Infection. 2024 Aug;52(4):1527-1538. doi: 10.1007/s15010-024-02284-z. Epub 2024 May 10. Infection. 2024. PMID: 38727926 Free PMC article.
-
Impact of a Bundle of Interventions on Quality-of-Care Indicators for Staphylococcus aureus Bacteraemia: A Single-Centre, Quasi-Experimental, Before-After Study.Antibiotics (Basel). 2024 Jul 12;13(7):646. doi: 10.3390/antibiotics13070646. Antibiotics (Basel). 2024. PMID: 39061328 Free PMC article.
-
Consequences of the COVID-19 Pandemic on the Incidence, Management and Outcomes of Staphylococcus aureus Bacteraemia: Experience in a Spanish Hospital.Pathogens. 2024 Sep 29;13(10):847. doi: 10.3390/pathogens13100847. Pathogens. 2024. PMID: 39452719 Free PMC article.
-
Adherence to Staphylococcus aureus Bacteremia Management Recommendations Before, During, and After the COVID-19 Pandemic: Prognostic Implications.Antibiotics (Basel). 2025 Jun 18;14(6):615. doi: 10.3390/antibiotics14060615. Antibiotics (Basel). 2025. PMID: 40558205 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous